CytoDyn (OTC: CYDY) Monoclonal antibody HIV treatment w potential FDA approval in 2019
CytoDyn Inc. (OTC: CYDY) CEO Interview with Nader Pourhassan, Ph.D, discussing CytoDyn’s PRO140 monoclonal antibody therapy for HIV and cancer. The company is at a key inflection point, with potential FDA approval for PRO140 for […]
